BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li YC, Yang CS, Zhou WL, Li HS, Han YJ, Wang QS, Wu HB. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression. World J Gastroenterol 2018; 24(4): 494-503 [PMID: 29398870 DOI: 10.3748/wjg.v24.i4.494]
URL: https://www.wjgnet.com/1948-5182/full/v24/i4/494.htm
Number Citing Articles
1
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, Rakesh Kumar. FAPI PET/CT Imaging—An Updated ReviewDiagnostics 2023; 13(12): 2018 doi: 10.3390/diagnostics13122018
2
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utilityClinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y
3
Bin Yi, Tian Wu, Nan Zhu, Yao Huang, Xiaoyu Yang, Lei Yuan, Yingjun Wu, Xiaofei Liang, Xiaoqing Jiang. The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinomaJournal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00818-3
4
Shuai Huang, Kai Luo, Li Jiang, Xu-Dong Zhang, Ying-Hao Lv, Ren-Feng Li. PCBP1 regulates the transcription and alternative splicing of metastasis‑related genes and pathways in hepatocellular carcinomaScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02642-z
5
Mikhail Kesler, Charles Levine, Dov Hershkovitz, Eyal Mishani, Yoram Menachem, Hedva Lerman, Yaniv Zohar, Oren Shibolet, Einat Even-Sapir. 68Ga-Labeled Prostate-Specific Membrane Antigen Is a Novel PET/CT Tracer for Imaging of Hepatocellular Carcinoma: A Prospective Pilot StudyJournal of Nuclear Medicine 2019; 60(2): 185 doi: 10.2967/jnumed.118.214833
6
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic StrategiesCancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
7
Laura Evangelista, Paolo Artoli, Paola Bartoletti, Antonio Bignotto, Federica Menegatti, Marco Frigo, Stefania Antonia Sperti, Laura Vendramin, Diego Cecchin. Radiology‐Nuclear Medicine Diagnostic Imaging2023; : 788 doi: 10.1002/9781119603627.ch29
8
Shiori Meguro, Daisuke Suzuki, Toru Kawai, Takanori Kyokane, Yoichiro Aoshima, Yasunori Enomoto, Haruna Yagi, Hideya Kawasaki, Isao Kosugi, Hiroe Tsukui, Satoshi Baba, Toshihide Iwashita. A case of an alpha-fetoprotein-producing gastric so-called carcinosarcoma with enteroblastic differentiationHuman Pathology: Case Reports 2020; 22: 200420 doi: 10.1016/j.ehpc.2020.200420
9
Woo-Ri Shin, Dae-Young Park, Ji Hun Kim, Jin-Pyo Lee, Nguyen Quang Thai, In-Hwan Oh, Simranjeet Singh Sekhon, Wooil Choi, Sung Yeon Kim, Byung-Kwan Cho, Sun Chang Kim, Jiho Min, Ji-Young Ahn, Yang-Hoon Kim. Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinomaJournal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01391-z
10
Pietro Zucchetta, Carmelo Lacognata, Francesca Girardi, Alessandro Spimpolo, Filippo Crimì, Giulio Cabrelle, Chiara Zanon, Patrizia Boccagni, Laura Evangelista, Diego Cecchin, Umberto Cillo. [18F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantationNuclear Medicine Communications 2022; 43(3): 359 doi: 10.1097/MNM.0000000000001518
11
Ren-Cai Lu, Bo She, Wen-Tao Gao, Yun-Hai Ji, Dong-Dong Xu, Quan-Shi Wang, Shao-Bo Wang. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospectsWorld Journal of Gastroenterology 2019; 25(32): 4682-4695 doi: 10.3748/wjg.v25.i32.4682
12
Gebing Yao, Jikai Yin, Qing Wang, Rui Dong, Jianguo Lu. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer CellsBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2560650
13
Youcai Li, Yin Zhang, Qi Fang, Xiaoyao Zhang, Peng Hou, Hubing Wu, Xinlu Wang. Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging 2021; 48(8): 2599 doi: 10.1007/s00259-020-05119-9
14
Kevser Oksuzoglu, Tunc Ones, Salih Ozguven, Sabahat Inanir, Halil Turgut Turoglu, Emine Bozkurtlar, Cigdem Ataizi Celikel, Tanju Yusuf Erdil. Change in standardized uptake values in delayed 18F-FDG positron emission tomography images in hepatocellular carcinomaMedicine 2018; 97(42): e12817 doi: 10.1097/MD.0000000000012817
15
Esther Mena, Joanna Shih, Joon-Yong Chung, Jennifer Jones, Atoosa Rabiee, Cecilia Monge, Baris Turkbey, Liza Lindenberg, Kilian E. Salerno, Michael Kassin, Brad Wood, Jonathan Hernandez, Roberto Maass-Moreno, Babak Saboury, Neha Jakhete, Jason K. Molitoris, Keith R. Unger, Peter L. Choyke, Freddy E. Escorcia, Johannes Stortz. Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinomaPLOS ONE 2022; 17(11): e0277407 doi: 10.1371/journal.pone.0277407
16
Qianhui Dou, Aaron K. Grant, Patricia Coutinto de Souza, Marwan Moussa, Imad Nasser, Muneeb Ahmed, Leo L. Tsai. Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass SpectrometryRadiology: Imaging Cancer 2024; 6(2) doi: 10.1148/rycan.230056
17
Kashif Rafiq Zahid, Shun Yao, Abdur Rehman Raza Khan, Umar Raza, Deming Gou. mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silicoFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01000
18
Hao Yang, Jingyi Wang, Gang Huang. Small extracellular vesicles in metabolic remodeling of tumor cells: Cargos and translational applicationFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1009952